WAVE Life Sciences (WVE) Competitors $7.81 -0.19 (-2.40%) As of 12:49 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock WVE vs. ABVX, AXSM, NUVL, MRUS, CRSP, TGTX, ACAD, MENS, CYTK, and KRYSShould you be buying WAVE Life Sciences stock or one of its competitors? The main competitors of WAVE Life Sciences include Abivax (ABVX), Axsome Therapeutics (AXSM), Nuvalent (NUVL), Merus (MRUS), CRISPR Therapeutics (CRSP), TG Therapeutics (TGTX), ACADIA Pharmaceuticals (ACAD), Jyong Biotech (MENS), Cytokinetics (CYTK), and Krystal Biotech (KRYS). These companies are all part of the "pharmaceutical products" industry. WAVE Life Sciences vs. Its Competitors Abivax Axsome Therapeutics Nuvalent Merus CRISPR Therapeutics TG Therapeutics ACADIA Pharmaceuticals Jyong Biotech Cytokinetics Krystal Biotech Abivax (NASDAQ:ABVX) and WAVE Life Sciences (NASDAQ:WVE) are both medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their media sentiment, valuation, profitability, dividends, analyst recommendations, earnings, institutional ownership and risk. Does the media prefer ABVX or WVE? In the previous week, WAVE Life Sciences had 5 more articles in the media than Abivax. MarketBeat recorded 15 mentions for WAVE Life Sciences and 10 mentions for Abivax. WAVE Life Sciences' average media sentiment score of 1.15 beat Abivax's score of 1.06 indicating that WAVE Life Sciences is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Abivax 5 Very Positive mention(s) 1 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive WAVE Life Sciences 6 Very Positive mention(s) 3 Positive mention(s) 4 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Is ABVX or WVE more profitable? Abivax's return on equity of 0.00% beat WAVE Life Sciences' return on equity.Company Net Margins Return on Equity Return on Assets AbivaxN/A N/A N/A WAVE Life Sciences N/A -78.45%-41.51% Do insiders and institutionals hold more shares of ABVX or WVE? 47.9% of Abivax shares are owned by institutional investors. Comparatively, 89.7% of WAVE Life Sciences shares are owned by institutional investors. 24.0% of WAVE Life Sciences shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth. Which has higher valuation and earnings, ABVX or WVE? WAVE Life Sciences has higher revenue and earnings than Abivax. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAbivaxN/AN/A-$190.71MN/AN/AWAVE Life Sciences$108.30M11.47-$97.01M-$0.90-8.67 Which has more volatility and risk, ABVX or WVE? Abivax has a beta of 0.58, indicating that its stock price is 42% less volatile than the S&P 500. Comparatively, WAVE Life Sciences has a beta of -1.15, indicating that its stock price is 215% less volatile than the S&P 500. Do analysts recommend ABVX or WVE? Abivax presently has a consensus price target of $92.33, suggesting a potential upside of 9.01%. WAVE Life Sciences has a consensus price target of $20.07, suggesting a potential upside of 157.10%. Given WAVE Life Sciences' higher probable upside, analysts plainly believe WAVE Life Sciences is more favorable than Abivax.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Abivax 0 Sell rating(s) 0 Hold rating(s) 7 Buy rating(s) 1 Strong Buy rating(s) 3.13WAVE Life Sciences 0 Sell rating(s) 1 Hold rating(s) 14 Buy rating(s) 0 Strong Buy rating(s) 2.93 SummaryWAVE Life Sciences beats Abivax on 8 of the 13 factors compared between the two stocks. Get WAVE Life Sciences News Delivered to You Automatically Sign up to receive the latest news and ratings for WVE and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding WVE and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart WVE vs. The Competition Export to ExcelMetricWAVE Life SciencesMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$1.24B$3.10B$5.76B$9.85BDividend YieldN/A2.28%6.66%4.49%P/E Ratio-8.6820.9382.4826.51Price / Sales11.47367.07500.41161.56Price / CashN/A43.5325.7028.92Price / Book8.878.0510.816.51Net Income-$97.01M-$53.35M$3.28B$266.22M7 Day Performance-21.37%-0.93%-0.43%-1.21%1 Month Performance-10.77%5.97%6.47%3.32%1 Year Performance52.50%10.33%49.57%23.49% WAVE Life Sciences Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)WVEWAVE Life Sciences4.7287 of 5 stars$7.81-2.4%$20.07+157.1%+44.1%$1.24B$108.30M-8.68240Trending NewsAnalyst ForecastABVXAbivax3.2547 of 5 stars$81.03-0.7%$92.33+13.9%+574.1%$6.10BN/A0.0061News CoveragePositive NewsShort Interest ↓AXSMAxsome Therapeutics4.7729 of 5 stars$121.44-0.3%$178.00+46.6%+36.1%$6.06B$385.69M-23.95380News CoveragePositive NewsAnalyst ForecastInsider TradeNUVLNuvalent3.2422 of 5 stars$76.55+0.7%$120.80+57.8%-4.9%$5.54BN/A-15.6740News CoveragePositive NewsAnalyst ForecastMRUSMerus3.0238 of 5 stars$65.57-0.8%$88.75+35.4%+32.0%$4.96B$36.13M-11.9237News CoveragePositive NewsCRSPCRISPR Therapeutics3.5882 of 5 stars$51.89-2.2%$71.60+38.0%+16.4%$4.72B$37.31M-9.55460Analyst RevisionTGTXTG Therapeutics4.3988 of 5 stars$28.69-0.9%$46.25+61.2%+40.2%$4.55B$329M77.44290News CoveragePositive NewsACADACADIA Pharmaceuticals4.0426 of 5 stars$26.05-0.7%$28.88+10.8%+57.2%$4.39B$957.80M19.59510Analyst RevisionMENSJyong BiotechN/A$57.00+2.7%N/AN/A$4.33BN/A0.0031News CoverageCYTKCytokinetics4.1774 of 5 stars$36.16-3.2%$71.58+98.0%-8.4%$4.31B$85.74M-7.06250Trending NewsAnalyst ForecastInsider TradeOptions VolumeKRYSKrystal Biotech4.8404 of 5 stars$147.94-1.9%$210.38+42.2%-19.6%$4.31B$290.52M30.25210Positive News Related Companies and Tools Related Companies ABVX Alternatives AXSM Alternatives NUVL Alternatives MRUS Alternatives CRSP Alternatives TGTX Alternatives ACAD Alternatives MENS Alternatives CYTK Alternatives KRYS Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:WVE) was last updated on 9/4/2025 by MarketBeat.com Staff From Our Partners“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredWhat's the Best Way to Lower RMD Taxes?Turning 73 triggers a key IRS rule: you must begin taking required minimum distributions (RMDs) from certain r...SmartAsset | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredWashington prepares for warWhile the headlines obsess over overseas conflicts, Washington has been quietly preparing for something much b...Porter & Company | SponsoredBuffett, Gates and Bezos Quietly Dumping Stocks—Here's WhyImagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA ...Banyan Hill Publishing | SponsoredFree: The Crypto Summit That Could Change Your Life27 industry leaders share urgent market intel (free access)... For a very limited time, you can claim your ...Crypto 101 Media | SponsoredThis Massive Market is Ripe for Disruption by this NasdaqFanatics Hit $31B. This Nasdaq Company Is Building the Next Wave Fanatics built a merch empire by owning th...i2i Marketing Group, LLC | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding WAVE Life Sciences Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share WAVE Life Sciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free WVE Stock Alerts